Cheryl Maley is the Chief Executive Officer of Starpharma, a role they have held since 2024. They have international and country leadership experience across ANZ, the USA, and Asia in rare and specialty disease and oncology, with prior roles at Abbott, AbbVie, and Novartis in Australia and New Zealand. They also served as a Non-Executive Director for Clarity Pharmaceuticals (2023–2024) and Medlab Clinical (2021–2023) and acted as CEO and Strategic Advisor at Biointelect (2022–2023), in addition to earlier leadership at Oliver Wight Asia Pacific (2000–2006). They earned a Bachelor of Science and a Master of Business Administration in International Business from the University of New England.
This person is not in the org chart
This person is not in any teams
This person is not in any offices